510(k) third-party review program
This article was originally published in The Gray Sheet
Executive Summary
FDA expects to receive 140 premarket notifications annually from outside reviewers under the "Accredited Persons" program mandated to begin Nov. 21 by the FDA Modernization Act, the agency says in an Oct. 30 Federal Register notice. FDA anticipates accrediting 35 third parties, each of which is expected to process four 510(k)s a year. Since the inception of its third-party review pilot in August 1996, FDA has received thirty-two 510(k)s, agency staffers say
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.